Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» B-cell lymphoma
B-cell lymphoma
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
Fierce Pharma
Bristol Myers Squibb
Breyanzi
B-cell lymphoma
CAR-T
ASH 2022
Flag link:
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma
Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma
CP Wire
Kite Pharma
Gilead Sciences
EMA
CHMP
Yescarta
B-cell lymphoma
Flag link:
Why ProNAi Could Be the Biggest Loser at ASCO
Why ProNAi Could Be the Biggest Loser at ASCO
24/7 Wall St
ProNai
ASCO 2016
PNT2258
B-cell lymphoma
Flag link:
ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition
ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition
Yahoo/BusinessWire
Immunogen
IMGN529
B-cell lymphoma
Flag link:
Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma
Yahoo
Dynavax
TLR-9
immuno-oncology
B-cell lymphoma
SD-101
Flag link:
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
Yahoo/Fly on the Wall
AbbVie
ABT-199
GDC-0199
B-cell lymphoma
ASCO
Flag link:
